In an era of increasing and costly cyber-attacks in health care, physician practices must arm themselves with technical controls as well as internal protections to reduce their risk, according to Michael C.
Having four generations of physicians working in the same practice is both a blessing and a significant source of complications, said Haydn Shaw, CSP, at the LUGPA annual meeting in Chicago.
Private equity firms’ acquisition of physician practices has escalated in recent years, and urology practices are currently garnering great interest due to an increased demand for services from an aging population and a low supply of urologists.
Cass Schaedig, vice president of provider analytics, ION Solutions for AmerisourceBergen, talks with Urology Times about the value of benchmarking in patient care, practice management, and health policy.
Among the guideline’s recommendations is that active surveillance should serve as the preferred method of care for low-risk localized prostate cancer.
The update provides evidence-based recommendations for different patient risk groups and specifies the most effective forms of the treatment for patients with prostate cancer.
Cancer patients taking certain immunotherapy drugs may be more susceptible to developing autoimmune joint and tissue diseases, including inflammatory arthritis, according to a recent study.
A recent study has found that genetic predictors of normal PSA levels in healthy men could be used to improve the accuracy of PSA-based prostate cancer screening.
A recent review of medical literature adds to the debate surrounding medical expulsive therapy for stone disease.
Researchers at UCLA have discovered a previously unrecognized type of progenitor cell in inflamed areas of the prostate that have the ability to initiate cancer in response to genetic changes.